IE66680B1 - The use of imexon as an immune suppressive - Google Patents

The use of imexon as an immune suppressive

Info

Publication number
IE66680B1
IE66680B1 IE244889A IE244889A IE66680B1 IE 66680 B1 IE66680 B1 IE 66680B1 IE 244889 A IE244889 A IE 244889A IE 244889 A IE244889 A IE 244889A IE 66680 B1 IE66680 B1 IE 66680B1
Authority
IE
Ireland
Prior art keywords
imexon
cell
immune
proliferation
cells
Prior art date
Application number
IE244889A
Other languages
English (en)
Other versions
IE892448L (en
Inventor
Dieter Herremann
Rainer Haag
Elmar Bosies
Wolfgang Kampe
Uwe Bicker
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IE892448L publication Critical patent/IE892448L/en
Publication of IE66680B1 publication Critical patent/IE66680B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IE244889A 1988-07-28 1989-07-27 The use of imexon as an immune suppressive IE66680B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3825667A DE3825667A1 (de) 1988-07-28 1988-07-28 Verwendung von imexon als immunsuppressivum

Publications (2)

Publication Number Publication Date
IE892448L IE892448L (en) 1990-01-28
IE66680B1 true IE66680B1 (en) 1996-01-24

Family

ID=6359767

Family Applications (1)

Application Number Title Priority Date Filing Date
IE244889A IE66680B1 (en) 1988-07-28 1989-07-27 The use of imexon as an immune suppressive

Country Status (14)

Country Link
EP (1) EP0352652B1 (fr)
JP (1) JP2848634B2 (fr)
KR (1) KR0135757B1 (fr)
AT (1) ATE117551T1 (fr)
AU (1) AU619027B2 (fr)
CA (1) CA1333771C (fr)
DE (2) DE3825667A1 (fr)
DK (1) DK175199B1 (fr)
HU (1) HU206827B (fr)
IE (1) IE66680B1 (fr)
IL (1) IL91138A (fr)
PH (1) PH26684A (fr)
PT (1) PT91293B (fr)
ZA (1) ZA895710B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06006291A (es) * 2003-12-08 2006-08-23 Univ Arizona Composiciones anti-cancer sinergisticas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2530398A1 (de) * 1975-07-08 1977-01-27 Boehringer Mannheim Gmbh Organische verbindung
DE2736296A1 (de) * 1977-08-12 1979-02-22 Boehringer Mannheim Gmbh Verwendung von 2-cyan-aziridin und seinen derivaten zur immunstimulierung

Also Published As

Publication number Publication date
DK363389D0 (da) 1989-07-21
PT91293B (pt) 1995-03-01
DE3825667C2 (fr) 1991-06-27
JP2848634B2 (ja) 1999-01-20
PH26684A (en) 1992-09-15
KR900001369A (ko) 1990-02-27
ZA895710B (en) 1990-04-25
IL91138A0 (en) 1990-03-19
DE58908926D1 (de) 1995-03-09
EP0352652A2 (fr) 1990-01-31
PT91293A (pt) 1990-02-08
IL91138A (en) 1994-10-21
HUT52378A (en) 1990-07-28
AU3887789A (en) 1990-02-01
KR0135757B1 (ko) 1998-04-23
HU206827B (en) 1993-01-28
IE892448L (en) 1990-01-28
AU619027B2 (en) 1992-01-16
EP0352652B1 (fr) 1995-01-25
EP0352652A3 (fr) 1991-09-04
DE3825667A1 (de) 1990-03-15
DK363389A (da) 1990-01-29
JPH0288521A (ja) 1990-03-28
DK175199B1 (da) 2004-07-05
CA1333771C (fr) 1995-01-03
ATE117551T1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
RU2141844C1 (ru) Фармацевтическое соединение
HU220995B1 (hu) TNF-antagonisták alkalmazása megnövekedett interleukin-6 szérumszinttel járó szepszis kezelésére szolgáló gyógyszerkészítmény előállítására
JPS62240619A (ja) 制癌剤
US5538951A (en) Pharmaceutical preparation for the therapy of immune deficiency conditions
JPH0662407B2 (ja) 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤
US5547971A (en) Use of leflunomide for inhibiting interleukin 8
CN105770891A (zh) TACI-Ig 融合蛋白如ATACICEPT 用于制备治疗红斑狼疮的药物的用途
US5369119A (en) Use of imexon as an immune suppressive and pharmaceutical compositions containing imexon
Larionov Some biological and clinical results from the investigations of the chloroethylamines as anti-tumour drugs
IE66680B1 (en) The use of imexon as an immune suppressive
NL194430C (nl) Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
EP0099186B1 (fr) Compositions pharmaceutiques
US3311539A (en) Method of treating traumatized nerves
US3864486A (en) Therapeutic compositions of bromazepam and sulpiride
EP1623709A1 (fr) Remede contre la polyarthrite rhumatoide
US6136788A (en) Pharmaceutical preparation for the therapy of immune deficiency conditions
SU1097334A1 (ru) Способ лечени ишемической болезни сердца
RU1638852C (ru) Способ лечения атопического дерматита
DE3844655A1 (de) Verwendung von imexon als immunsuppressivum
US5814611A (en) Pharmaceutical for the therapy of immune deficiency conditions
JPH0435476B2 (fr)
KR100191446B1 (ko) 파클리탁셀 함유 전신성 홍반성 낭창치료제
US3772438A (en) Antibiotic compositions containing coumermycin
JPS60184012A (ja) 免疫調整剤
RU2038085C1 (ru) Вещество "силлард", обладающее адаптогенной активностью

Legal Events

Date Code Title Description
MM4A Patent lapsed